There is an increasing demand for high resolution multimodality imaging of research animals, such as mice and rats, to allow non-invasive monitoring of disease models and therapeutic interventions. This project focuses on the development of a new positron emission tomography (PET) imaging system that can be operated inside a magnetic resonance imaging (MRI) system. Once complete, this system will allow simultaneous high resolution PET/MRI imaging of research animals.
Despite many recent advances in biotechnology, the methods for monitoring water quality remain largely unchanged for the past century. We will use next-generation DNA sequencing technology to guide the design of novel DNA-based tests to improve sensitivity and specificity of water quality testing.
We will evaluate treatments for peanut allergy, the most severe and persistent form of food allergy. The proposed interventions are based on targeted delivery of interleukin-10 (IL-10) to the intestine. IL-10 is a protein that is known to be a potent regulator of the immune system. enGene has developed EG-10, a novel, state-of-the-art technology that can effectively induce a robust and transient production of interleukin-10 in the intestine, i.e., the site where food absorption occurs and food allergy is initiated.
This project will develop, pilot and evaluate a training program for job coaches and other related support providers to person with Autism Spectrum Disorder, using several sequential steps, as follows. (1) We will conduct an environmental scan of existing job coach training curriculum. (2) We will present this information in focus groups across Alberta that include adults with autism, family members, job coahces, employes, and other key stakeholders that support the autism community and understand the role of, and potential issues for, job coaches in autism.
Cancer is one of the leading causes of death worldwide with approximately 8 million deaths in 2010. Most cancer treatments lack specificity and affect the whole body, with toxic effects on both cancerous and normal cells. The cytotoxic effect of a new therapy developed by Biomark Technologies, Inc. targeting cancer cells will be assessed. Biomark Technologies Inc. has found that the expression levels of the gene coding for the protein SSAT 1 is upregulated in cancer cells.
Our gastro-intestinal tract is colonized by billions of microorganisms that constitute the intestinal flora or microbiota. These microorganisms, primarily bacteria, are required for our development and physiology; however, changes in the "normal" composition of the microbiota, referred to as dysbiosis, have been linked to chronic inflammatory diseases in humans. Currently, a major research effort is to understand what these commensal bacteria are, how they maintain health, and how their dysregulation causes disease.
Digital Pathology provides a great reliable source for cancer diagnosis; however, this relatively new technique lacks an appropriate method of regulation and standardization. As a result the information obtained from cancer imaging system might suffer from inconsistency of the results (repeatability and reproducibility issues). Working with the BC Cancer Research Center, Logipath Medical Inc. has developed a number of quantitative pathology systems some of which have been spun off to commercial entities.
Prostate cancer (PCa) is the most common cancer affecting Western men. Unfortunately, treatment for advanced prostate cancer is strictly palliative and lethal treatment-resistant disease eventually arises (castrate-resistant prostate cancer (CRPC)). Interrogating the genome of pre and post CRPC allows for the identification genetic differences that drive progression and resistance, representing candidate therapeutic targets and molecular biomarkers.
A cochlear implant (CI) is a complex electronic device designed to provide the sensation of sound to profoundly deaf or severely hard-of-hearing individuals. Imaging of the implanted CI electrode would assist manufacturers in verifying the efficacy of their designs and would also provide important information to clinics for programming CIs post-surgery. However, the size and position of the cochlea in the body make it difficult to image using clinical imaging scanners.
Bleeding following traumatic injury is the leading cause of early cause of death. Currently these patients are treated based on the results of time consuming laboratory tests resulting in inappropriate usage of blood products and poor survival rates. Rapid recognition of defects in clotting mechanism is necessary to stop bleeding in trauma patients.